Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration. Ghazawi FM, Lim M, Dutz JP, Kirchhof MG, et al. Int J Dermatol 2020;59:1043-1056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ghazawi FM, Lim M, Dutz JP, Kirchhof MG, et al. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration. Int J Dermatol 2020;59:1043-1056.
PMID: 32621284